A moderated session highlighting ongoing efforts by industry, clinical educators, public health professionals, and frontline providers to strengthen rapid detection, reporting, and prevention of substandard and falsified (SF) medical products. Public awareness and informed health-seeking behavior are essential to reducing exposure risks. Panelists will share evidence-based and locally grounded approaches that empower patients and communities, ranging from provider-led education and risk communication to cross-sector collaboration. The session will explore how partnerships among healthcare professionals, regulators, and civil society can build public trust, enhance medicine safety, and ensure equitable access to quality-assured products.
A moderated session highlighting ongoing efforts by industry, clinical educators, public health professionals, and frontline providers to strengthen rapid detection, reporting, and prevention of substandard and falsified (SF) medical products. Public awareness and informed health-seeking behavior are essential to reducing exposure risks. Panelists will share evidence-based and locally grounded approaches that empower patients and communities, ranging from provider-led education and risk communication to cross-sector collaboration. The session will explore how partnerships among healthcare professionals, regulators, and civil society can build public trust, enhance medicine safety, and ensure equitable access to quality-assured products.
BESAFE2025 besafe@jh.eduProblemas técnicos?
Si tienes problemas de reproducción, prueba a ajustar la calidad o a actualizar la página.
Preguntas para los ponentes?
Usa la pestaña de Preguntas y respuestas para enviar preguntas que podrían abordarse en sesiones de seguimiento.
